目次

Table of Contents

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 INCLUSIONS & EXCLUSIONS
1.3.2 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 GLOBAL MARKET ESTIMATION
2.2.2 SEGMENTAL MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER AND COUNTRY, 2023
4.3 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023
4.4 PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing pharmaceutical industry
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries
5.2.1.3 Increasing adoption of single-use technologies
5.2.1.4 Increasing purity requirement in pharmaceutical and biotechnology manufacturing
5.2.1.5 Adoption of continuous manufacturing process
5.2.2 RESTRAINTS
5.2.2.1 Membrane fouling and breakage issues
5.2.2.2 High capital investments required for new production facilities
5.2.2.3 Technological limitations
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Advances in nanofiber technology
5.2.3.3 Growing need for high-efficiency filters for vaccine production
5.2.4 CHALLENGES
5.2.4.1 Increased cost and reduced speed and yield of filters
5.2.4.2 Survival of small players and new entrants
5.2.4.3 Stringent regulatory compliance
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Microfiltration
5.3.1.2 Ultrafiltration
5.3.1.3 Nanofiltration
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Single-Use Technology
5.3.2.2 Electrospun Microfibers
5.3.2.3 Photocatalytic Filtration
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Chromatography
5.3.3.2 Centrifugation
5.3.3.3 Microfluidics
5.4 SUPPLY CHAIN ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS,
BY KEY PLAYERS, 2021-2023
5.6.2 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023
5.7 ECOSYSTEM ANALYSIS
5.7.1 RAW MATERIAL VENDORS IN PHARMACEUTICAL FILTRATION MARKET
5.7.2 PRODUCT VENDORS IN PHARMACEUTICAL FILTRATION MARKET
5.7.3 END USERS IN PHARMACEUTICAL FILTRATION MARKET
5.7.4 REGULATORY BODIES IN PHARMACEUTICAL FILTRATION MARKET
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9 PATENT ANALYSIS
5.9.1 PATENT METHODOLOGY
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
5.10 KEY CONFERENCES & EVENTS
5.11 REGULATORY LANDSCAPE
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.11.2 REGULATORY FRAMEWORK
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 ROLE OF STAKEHOLDER IN BUYING PROCESS
5.13.3 BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION MARKET
5.14 CASE STUDY ANALYSIS
5.14.1 COST SAVING/OPTIMIZATION
5.14.2 SUPPLY CHAIN SIMPLIFICATION
5.14.3 COST SAVING AND SYSTEM OPTIMIZATION
5.14.4 INTERMITTENT PREMATURE FILTER FOULING SOLVED
5.15 INVESTMENT/FUNDING SCENARIO
5.16 TRADE DATA ANALYSIS
5.17 IMPACT OF AI ON PHARMACEUTICAL FILTRATION MARKET

6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 FILTERS
6.2.1.1 Membrane Filters
6.2.1.1.1 Polyethersulfone (PES)
6.2.1.1.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth
6.2.1.1.2 Polyvinylidene difluoride (PVDF)
6.2.1.1.2.1 Nontoxic nature to increase demand for PVDF filters
6.2.1.1.3 Nylon
6.2.1.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth
6.2.1.1.4 Polytetrafluoroethylene (PTFE)
6.2.1.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ
6.2.1.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA)
6.2.1.1.5.1 Growing analytical and research applications to drive market
6.2.1.1.6 Polycarbonate track-etched (PCTE)
6.2.1.1.6.1 Wide use in cell biology and analytical testing applications
6.2.1.1.7 Other materials
6.2.1.2 Depth filters
6.2.1.2.1 Diatomaceous earth
6.2.1.2.1.1 Increased use in biotechnology industry for cell clarification
6.2.1.2.2 Cellulose
6.2.1.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth
6.2.1.2.3 Activated carbon
6.2.1.2.3.1 Reliable and cost-effective activated carbon filters supporting pharmaceutical manufacturing operations
6.2.1.2.4 Perlite
6.2.1.2.4.1 Lower density of perlite provides more purity than diatomaceous earth
6.2.1.2.5 Other depth filter media
6.2.1.3 Air filters
6.2.1.4 Virus filters
6.2.1.5 Other filters
6.2.2 OTHER CONSUMABLES
6.2.2.1 FILTRATION ASSEMBLIES
6.2.2.1.1 Microfiltration assemblies
6.2.2.1.1.1 Growing demand for high-quality products to support segment growth
6.2.2.1.2 Ultrafiltration assemblies
6.2.2.1.2.1 Stringent regulatory requirements likely to support segment growth
6.2.2.1.3 Nanofiltration assemblies
6.2.2.1.3.1 Increasing demand for high-purity biopharmaceuticals to propel segment growth
6.2.2.1.4 Other filtration assemblies
6.2.3 FILTER HOLDERS
6.2.3.1 Filter holders provide structural support to membrane filters
6.2.4 FILTRATION ACCESSORIES
6.2.4.1 Increasing adoption of pharmaceutical filtration products to support growth
6.3 SYSTEMS
6.3.1 SINGLE-USE SYSTEMS
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption
6.3.2 REUSABLE SYSTEMS
6.3.2.1 Reusable systems widely used for large-scale manufacturing

7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE
7.1 INTRODUCTION
7.2 MICROFILTRATION
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH
7.3 ULTRAFILTRATION
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES
TO DRIVE GROWTH
7.4 NANOFILTRATION
7.4.1 RISING DEMAND IN BIOTECHNOLOGY INDUSTRY
TO SUPPORT MARKET GROWTH
7.5 OTHER TECHNIQUES

8 PHARMACEUTICAL FILTRATION MARKET, BY TYPE
8.1 INTRODUCTION
8.2 STERILE FILTRATION
8.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH
8.3 NON-STERILE FILTRATION
8.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH

9 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 FINAL PRODUCT PROCESSING
9.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION
9.2.1.1 Continuous requirement for API filtration
9.2.2 PROTEIN PURIFICATION
9.2.2.1 Recent advancements in protein therapeutic drugs
9.2.3 VACCINE AND ANTIBODY PROCESSING
9.2.3.1 Development of vaccines for viral diseases
9.2.4 FORMULATION AND FILLING SOLUTIONS
9.2.4.1 Demand for aseptic filling and bioburden reduction
9.2.5 VIRAL CLEARANCE
9.2.5.1 Growing development of therapeutic monoclonal antibodies
9.3 RAW MATERIAL FILTRATION
9.3.1 MEDIA BUFFER FILTRATION
9.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market
9.3.2 PREFILTRATION
9.3.2.1 High demand due to membrane fouling issues
9.3.3 BIOBURDEN TESTING
9.3.3.1 Strict quality control of biopharmaceuticals to drive market
9.4 CELL SEPARATION
9.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET
9.5 WATER PURIFICATION
9.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
9.6 AIR PURIFICATION
9.6.1 INCREASING ADOPTION OF GOOD MANUFACTURING PRACTICES TO DRIVE MARKET

10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION
10.1 INTRODUCTION
10.2 MANUFACTURING-SCALE OPERATION
10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILAR MANUFACTURING TO DRIVE MARKET
10.3 PILOT-SCALE OPERATION
10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH
10.4 R&D-SCALE OPERATION
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH

11 PHARMACEUTICAL FILTRATION MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
11.2.1 GROWING BIOLOGICS PRODUCTION TO DRIVE DEMAND
11.3 CMOS & CROS
11.3.1 INCREASING OUTSOURCING OF R&D SERVICES TO SUPPORT MARKET GROWTH
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 GROWING PHARMA-ACADEMIA COLLABORATIONS TO DRIVE ADOPTION

12 PHARMACEUTICAL FILTRATION MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS
12.2.2 US
12.2.2.1 US to dominate North American market during forecast period
12.2.3 CANADA
12.2.3.1 Growing government support for expanding biologics manufacturing facilities to support market
12.3 EUROPE
12.3.1 EUROPE: MACROECONOMIC ANALYSIS
12.3.2 GERMANY
12.3.2.1 Growing pharmaceutical R&D and manufacturing to drive market
12.3.3 UK
12.3.3.1 Growing awareness of quality of drugs increasing uptake of filtration products in drug discovery labs
12.3.4 FRANCE
12.3.4.1 Government investment in pharmaceutical industry to drive growth
12.3.5 ITALY
12.3.5.1 Investment in biotechnology R&D to boost market growth
12.3.6 SPAIN
12.3.6.1 Expansion of biomanufacturing facilities to support market
12.3.7 SWITZERLAND
12.3.7.1 Presence of key pharmaceutical and biopharmaceutical companies to support market
12.3.8 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS
12.4.2 CHINA
12.4.2.1 Improving drug development activities to drive market
12.4.3 JAPAN
12.4.3.1 Stringent regulatory guidelines to create need for advanced filtration products
12.4.4 INDIA
12.4.4.1 Favorable scenario for foreign direct investment to favor market growth
12.4.5 SOUTH KOREA
12.4.5.1 Increased export of drugs to support market growth
12.4.6 AUSTRALIA
12.4.6.1 Increasing demand for innovative filtration solutions to propel market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS
12.5.2 BRAZIL
12.5.2.1 Increased government investments in pharmaceutical R&D to drive market
12.5.3 MEXICO
12.5.3.1 Rising demand for chronic disease treatment to support market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS
12.6.2 GCC COUNTRIES
12.6.3 SAUDI ARABIA
12.6.3.1 Growing healthcare expenditure to boost market growth
12.6.4 UAE
12.6.4.1 Adoption of more efficient and precise filtration processes to aid market growth
12.6.5 REST OF GCC COUNTRIES
12.6.6 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 AFRICA: MACROECONOMIC ANALYSIS

13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022−2024
13.3 REVENUE SHARE ANALYSIS, 2019-2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Product footprint
13.5.5.3 Technique footprint
13.5.5.4 Application footprint
13.5.5.5 Region footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.7 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
13.8 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL FILTRATION VENDORS
13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
13.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES
13.10.2 DEALS
13.10.3 EXPANSIONS

14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 DANAHER CORPORATION
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 MERCK KGAA
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Expansions
14.1.2.3.2 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 SARTORIUS AG
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 3M COMPANY
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Key strengths
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses and competitive threats
14.1.5 REPLIGEN CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 PARKER HANNIFIN CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.7 EATON CORPORATION PLC
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.8 THERMO FISHER SCIENTIFIC, INC.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Expansions
14.1.9 DONALDSON COMPANY, INC.
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Expansions
14.1.10 PORVAIR PLC
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.11 ALFA LAVAL CORPORATE AB
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.12 CORNING INCORPORATED
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 MANN+HUMMEL
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.14 SAINT-GOBAIN
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.14.3.2 Expansions
14.1.15 STERIS PLC
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 MEISSNER FILTRATION PRODUCTS, INC.
14.2.2 AMAZON FILTERS LTD.
14.2.3 GRAVER TECHNOLOGIES, LLC.
14.2.4 MMS AG
14.2.5 ERTELALSOP
14.2.6 KASAG SWISS AG
14.2.7 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG
14.2.8 COLE-PARMER INSTRUMENT COMPANY, LLC
14.2.9 FILTROX AG
14.2.10 MEMBRANE SOLUTIONS

15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS